Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
36.36 USD | +1.56% | -2.26% | +31.93% |
May. 24 | Ptc Therapeutics Insider Sold Shares Worth $764,800, According to a Recent SEC Filing | MT |
May. 21 | Goldman Sachs Adjusts PTC Therapeutics Price Target to $32 From $18, Maintains Sell Rating | MT |
Financials (USD)
Sales 2024 * | 760M | Sales 2025 * | 844M | Capitalization | 2.79B |
---|---|---|---|---|---|
Net income 2024 * | -385M | Net income 2025 * | -187M | EV / Sales 2024 * | 3.01 x |
Net cash position 2024 * | 503M | Net cash position 2025 * | 424M | EV / Sales 2025 * | 2.8 x |
P/E ratio 2024 * |
-7.23
x | P/E ratio 2025 * |
-13.7
x | Employees | 1,022 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 97.58% |
Latest transcript on PTC Therapeutics, Inc.
1 day | +1.56% | ||
1 week | -2.26% | ||
1 month | +8.15% | ||
3 months | +13.80% | ||
6 months | +51.56% | ||
Current year | +31.93% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 52 | 19-09-30 |
Pierre Gravier
DFI | Director of Finance/CFO | 39 | 23-07-12 |
Ellen Welch
CTO | Chief Tech/Sci/R&D Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Glenn Steele
BRD | Director/Board Member | 79 | 15-06-14 |
Chairman | 72 | 01-07-31 | |
David Southwell
BRD | Director/Board Member | 63 | 05-11-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.35% | 14 M€ | -4.82% | ||
0.36% | 0 M€ | 0.00% | - | |
0.25% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 36.36 | +1.54% | 611,732 |
24-05-30 | 35.81 | +2.23% | 983,239 |
24-05-29 | 35.03 | -3.95% | 786,455 |
24-05-28 | 36.47 | -1.96% | 844,772 |
Delayed Quote Nasdaq, May 31, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+31.93% | 2.79B | |
+11.60% | 106B | |
-4.68% | 24.28B | |
-0.29% | 21.96B | |
-8.77% | 18.16B | |
-42.12% | 16.37B | |
-17.47% | 15.56B | |
+2.77% | 13.63B | |
+34.58% | 12.27B | |
+77.64% | 8.87B |
- Stock Market
- Equities
- PTCT Stock